“…1,–4 As a result, both the pharmaceutical industry and the regulatory agencies have taken a keen interest in analytical methods that can reliably characterize the properties of these macromolecules, their aggregates, and their associated drug-delivery systems. 1,–4 It should be noted that the term aggregates in the pharmaceutical industry refers to any self-associated nonnative species from dimers to visible particles 4 and therefore implies a very large range of sizes and types. 1,2 The analytical chemistry and particle characterization industries have responded with improvements in standard characterization techniques such as multiangle and dynamic (DLS) light scattering, electrophoretic mobility, and particle counters and with improvements in the performance of fractionation-based methods such as size exclusion chromatography, field flow fractionation, and automatic ultracentrifugation.…”